Top 10 Companies in the (R)-2-Methylpyrrolidine (CAS 41720-98-3) Market (2026): Market Leaders Powering Global Chemistry

MARKET INSIGHTS

Global (R)-2-Methylpyrrolidine (CAS 41720-98-3) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 54.7 million by 2034, exhibiting a CAGR of 6.9% during the forecast period.

(R)-2-Methylpyrrolidine is a chiral pyrrolidine derivative characterized by a five‑membered nitrogen‑containing heterocyclic ring with a methyl substituent at the 2‑position in the (R)-configuration. This optically active compound serves as a vital chiral building block and resolving agent in asymmetric synthesis, playing an essential role in the production of pharmaceutically active compounds, agrochemicals, and specialty fine chemicals. Its high enantiomeric purity makes it particularly valuable in drug discovery and the synthesis of chiral ligands for catalysis.

The market is experiencing steady growth driven by rising demand for enantiopure intermediates in pharmaceutical manufacturing, where regulatory agencies increasingly require single‑enantiomer drug formulations. Furthermore, expanding research activity in asymmetric catalysis and the growing pipeline of chiral active pharmaceutical ingredients (APIs) continue to support consumption. Key suppliers operating in this space include Thermo Fisher Scientific, TCI Chemicals, Sigma‑Aldrich (Merck KGaA), and Combi‑Blocks, among other specialized fine chemical manufacturers globally.

(R)-2-Methylpyrrolidine (CAS 41720-98-3) Market – View in Detailed Research Report

10. 1. Merck KGaA

Headquarters: Darmstadt, Germany

Merck KGaA leverages its extensive portfolio of chiral synthesis technologies to produce high‑purity (R)-2‑methylpyrrolidine, supporting drug discovery, peptide synthesis, and agrochemical development. Its integrated R&D and manufacturing footprint ensures consistent supply to major pharma clients.

Sustainability Initiatives:

• Investment in biocatalytic processes to reduce waste
• Commitment to lowering carbon footprint in production
• Partnerships with academic labs for greener synthesis

10. 2. Tokyo Chemical Industry Co., Ltd.

Headquarters: Tokyo, Japan

Tokyo Chemical Industry harnesses proprietary asymmetric catalysts to deliver scalable, high‑enantiomeric‑excess (R)-2‑methylpyrrolidine for pharmaceutical and agrochemical applications.

Sustainability Initiatives:

• Adoption of continuous‑flow reactors to lower energy use
• Use of renewable feedstocks in synthesis
• Compliance with ISO 14001 environmental standards

10. 3. Enamine Ltd.

Headquarters: Kyiv, Ukraine

Enamine offers rapid, cost‑effective production of (R)-2‑methylpyrrolidine for biotech R&D, with flexible scale and high purity.

Sustainability Initiatives:

• Lean manufacturing practices to reduce resource use
• Use of green solvents in synthesis
• Collaboration with European partners for technology transfer

10. 4. Biosynth AG

Headquarters: Basel, Switzerland

Biosynth AG combines enzyme‑based routes with advanced chromatographic purification to supply (R)-2‑methylpyrrolidine for fine‑chemical and pharmaceutical sectors.

Sustainability Initiatives:

• Enzyme‑based processes that cut waste
• Energy‑efficient purification steps
• Investment in renewable raw materials

10. 5. Oakwood Products, Inc.

Headquarters: Austin, Texas, USA

Oakwood Products delivers (R)-2‑methylpyrrolidine in neat liquid form, supporting large‑scale synthesis and R&D.

Sustainability Initiatives:

• Process optimization to lower solvent consumption
• Recycling of by‑products
• ISO 9001 certified quality system

10. 6. Apollo Scientific Ltd.

Headquarters: London, United Kingdom

Apollo Scientific supplies (R)-2‑methylpyrrolidine as a key chiral auxiliary for asymmetric transformations in academic and industrial settings.

Sustainability Initiatives:

• Use of biodegradable solvents
• Carbon‑neutral production targets
• Engagement with circular economy initiatives

10. 7. Hairui Fine Chemicals

Headquarters: Shanghai, China

Hairui Fine Chemicals has expanded its capacity to meet the rising demand for chiral intermediates in the Asia‑Pacific region, offering (R)-2‑methylpyrrolidine with >99% ee.

Sustainability Initiatives:

• Investment in green chemistry laboratories
• Reduction of heavy metal contamination
• Compliance with local environmental regulations

10. 8. AstaTech, Inc.

Headquarters: San Diego, California, USA (China operations)

AstaTech provides tailored (R)-2‑methylpyrrolidine solutions for catalyst development and custom synthesis projects.

Sustainability Initiatives:

• Partnerships with renewable energy providers
• Use of low‑toxicity solvents
• ISO 14001 certification

10. 9. Combi-Blocks Inc.

Headquarters: Madison, Wisconsin, USA

Combi-Blocks specializes in delivering (R)-2‑methylpyrrolidine for pharmaceutical intermediates, supporting complex synthetic routes.

Sustainability Initiatives:

• Lean production lines to reduce waste
• Waste minimization strategies
• Commitment to zero‑discharge policies

Download FREE Sample Report

Get Full Report

Market Outlook to 2034

Over the next eight years, the market remains expanding as pharmaceutical companies pursue single‑enantiomer drugs and the demand for precision chemistry grows. The shift toward greener manufacturing routes and the adoption of continuous‑flow processes will drive cost efficiencies and enhance supply‑chain resilience. Emerging biotech applications and the need for custom chiral intermediates will further propel consumption, especially in the Asia‑Pacific region.

Emerging Trends and Future Directions

The next phase of the market will see increased integration of biocatalysis and enzyme‑based synthesis, enabling scalable production of (R)-2‑methylpyrrolidine with lower environmental impact. Advances in machine‑learning‑guided catalyst design will accelerate discovery of new asymmetric transformations. Meanwhile, regulatory emphasis on chiral purity will push suppliers to adopt higher‑resolution techniques and real‑time monitoring, ensuring compliance and reducing batch failures.